India Glycols Ltd

BSE: 500201

39

total announcements

500201.BO · 15 min delayed

BSECompany UpdateM&A3d ago

India Glycols Ltd

Please find attached for Chemical Business.

India Glycols Ltd has announced a demerger of its business into two separate entities: IGL Spirits Ltd and Ennature Ltd, with IGL retaining Biobased Specialty Materials, Sustainable & Performance Chemicals, and Gases, while IGL Spirits will house Potable Spirits & Biofuels, and Ennature will have Nutraceuticals, plant-based APIs, and Biopolymers. The demerger aims to unlock shareholder value through sharper business focus and improved capital allocation.

Read more →📎 1 attachment
BSECompany Update▲ PositiveProduct Launch3d ago

India Glycols Ltd

Please find attached for Spirits and Bio Fuel.

India Glycols Ltd has announced an investor presentation for an analyst/institutional investor meeting, highlighting the growth of its Potable Spirits segment and the new Bio-fuels segment, which demonstrated a 100% revenue growth.

Read more →📎 1 attachment
BSECompany UpdateProduct Launch3d ago

India Glycols Ltd

Please find attached for Ennature Bio Pharma.

India Glycols Ltd has disclosed an investor presentation for Ennature Biopharma, highlighting the company's natural health and wellness business, including its botanical ingredients portfolio and nutraceutical segment.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change4d ago

India Glycols Ltd

Please find attached.

India Glycols Ltd has informed about the change in senior managerial personnel due to the transfer of employment to resulting companies post the Scheme of Arrangement.

Read more →📎 1 attachment
BSECompany UpdateM&A4d ago

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced the effectiveness of its Scheme of Arrangement, demerging into three separate entities: India Glycols Ltd, IGL Spirits Ltd, and Ennature Bio Pharma Ltd. Shareholders will receive shares in each of the new entities. The demerger aims to create separate companies with clear business focus, enabling improved management oversight and resource allocation.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change28 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced a schedule of analyst/institutional investor meeting on September 2nd, 2026, in Mumbai. The meeting will be a physical group meeting and will be based on publicly available information. No unpublished price sensitive information will be discussed.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change21 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced the appointment of new directors and key managerial personnel, including a chairman and managing director, as part of a scheme of arrangement. The appointments are subject to shareholder approval.

Read more →📎 1 attachment
BSECompany UpdateM&A21 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced a material update in connection with Ennature Bio Pharma Limited, a Scheme of Arrangement amongst India Glycols Limited and Ennature Bio Pharma Limited, and IGL Spirits Limited and their respective shareholders. The Board of Directors of India Glycols Limited has approved the appointment of six new directors and key managerial personnel, including a Managing Director and four Independent Directors. The appointments are subject to shareholder approval.

Read more →📎 1 attachment
BSECorp. ActionM&A21 Aug 2026

India Glycols Ltd

Please refer to attachment.

India Glycols Ltd has fixed the effective date and record date for the scheme of arrangement, which involves the demerger of the company into two resulting companies, Ennature Bio Pharma Ltd and IGL Spirits Ltd, with the allotment of shares to shareholders.

Read more →📎 1 attachment
BSECompany UpdateM&A21 Aug 2026

India Glycols Ltd

Please refer to attachment.

India Glycols Ltd has fixed the effective date and record date for the allotment of shares pursuant to a scheme of arrangement. The effective date is September 1, 2026, and the record date is September 2, 2026. The scheme involves the demerger of the company into two resulting companies, Ennature Bio Pharma Limited and IGL Spirits Limited, and the allotment of shares to the shareholders of the demerged company.

Read more →📎 1 attachment
BSECompany UpdateFundraise21 Aug 2026

India Glycols Ltd

Please find attached

India Glycols Ltd has announced the allotment of Equity Shares to successful applicants under its public issue, with 28,800 shares allotted to 1 successful applicant. The company has also obtained the listing and trading approval from NSE EMERGE and trading is expected to commence on August 21, 2026.

Read more →📎 1 attachment
BSECompany UpdateM&A20 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has received a certified true copy of the NCLT order dated 17th July, 2026, approving the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced its Q1FY27 Earnings Conference Call transcript, showing a strong start to the fiscal year with double-digit growth in gross revenue, EBITDA, and PAT. The company's net revenue was INR1,130 crores, up 9%, with a record EBITDA of INR170 crores. The business restructuring front has made progress, with NCLT approval and actions being taken as per the plan.

Read more →📎 1 attachment
BSEAGM/EGM19 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd has announced the outcome of its 42nd Annual General Meeting (AGM), where all 4 proposed resolutions were passed with the requisite majority. The company has also disclosed the voting results and the consolidated scrutinizer's report.

Read more →📎 1 attachment
BSEAGM/EGMResults19 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd held its 42nd Annual General Meeting (AGM) on August 19, 2026, through video conference. The meeting was attended by 52 members, and all four resolutions were passed with the requisite majority. The company provided remote e-voting facilities for the resolutions, which commenced on August 15, 2026, and ended on August 18, 2026. The scrutinizer, Ashish Saxena, was present to ensure a fair and transparent voting process. The meeting was conducted in compliance with the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSECompany UpdateRegulatory19 Aug 2026

India Glycols Ltd

Please find attached.

India Glycols Ltd clarifies on BSE query regarding volume movement, stating that there is no undisclosed information or event that needs to be disclosed under SEBI Listing Regulations.

Read more →📎 1 attachment
BSECompany UpdateRegulatory19 Aug 2026

India Glycols Ltd

Please find attached

India Glycols Ltd responded to a query from the National Stock Exchange (NSE) regarding a surge in trading volumes, stating that there is no undisclosed information or event concerning the company that needs to be disclosed under SEBI Listing Regulations. The company attributes the increased volume to market-driven factors and reaffirms its commitment to keeping the stock exchanges informed of all necessary information.

Read more →📎 1 attachment
BSECompany UpdateResults14 Aug 2026

India Glycols Ltd

Please find attached

India Glycols Ltd has made the audio recording of its Q1FY27 Earnings Conference Call available on its website, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
Page 1 of 2Next →